Lysyl oxidase (LOX), which is known to play a role in enzymatic COL1 cross-linking and fibrils maturation, has been shown to be overexpressed in breast carcinoma and responsible for metastatic niche formation (Levental et al., 2009). Here, LOX is linked to breast carcinoma.